Spinal fluid study seeks clues to brain damage after cardiac arrest
NCT ID NCT07481396
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to uncover the molecular causes of secondary brain injury in patients who survive cardiac arrest. Researchers will analyze cerebrospinal fluid from 60 participants using advanced techniques to identify changes in genes, proteins, and other molecules. The goal is to find new targets for future treatments, though this is an early-stage observational study, not a treatment trial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could identify new drug targets for preventing brain damage after cardiac arrest.
- What could go wrong
- This is an early observational study with only 60 participants, so findings may not lead directly to treatments and need further validation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC ARREST (CA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chungnam National University Hospital
RECRUITINGDaejeon, Jung-gu, 35015, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can targeted temperature control boost brain recovery after cardiac arrest?
- Blood test may forecast brain recovery after cardiac arrest
- Can a High-Tech CPR bundle boost heart restart rates?
- Could chilling the body after cardiac arrest save more brains?
- A simple bedside test may predict brain damage after cardiac arrest
- Can a neck patch spot a heartbeat faster than a Doctor's fingers?